• Tue news: Obesity pill race heats up. Express Scripts sues FTC. More ESMO data. Kairos IPO. Daiichi-Merck guided-missile cancer drug. See more on our front page

Provention Bio Co-promotion in diabetes

















I doubt the target base for promotion will be large enough to actually have openings for all experienced and successful Diabetes Reps. My guess is we will see more cuts in Diabetes even with the team build out for co promotional needs
 








Similar threads

Replies
14
Views
6K
Sanofi
anonymous
Replies
4
Views
1K
Sanofi
anonymous
Replies
14
Views
4K
Sanofi
Anonymous